B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and Fc gamma RIIb, which are modulated by anti-tumor necrosis factor therapy

dc.contributor.authorCatalán, D.
dc.contributor.authorKalergis Parra, Alexis Mikes
dc.date.accessioned2016-05-10T18:01:54Z
dc.date.available2016-05-10T18:01:54Z
dc.date.issued2010
dc.identifier.issn1478-6354
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/11980
dc.language.isoen
dc.relation.isformatofArthritis Research & Therapy No. 2 (12), p. 1-11.
dc.revistaArthritis Research & Therapyes_ES
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.otherArtritis reumatoidees_ES
dc.subject.otherLinfocitos B - Efectos de fármacoses_ES
dc.subject.otherAnticuerpos monoclonaleses_ES
dc.titleB cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and Fc gamma RIIb, which are modulated by anti-tumor necrosis factor therapyes_ES
dc.typeartículo
sipa.codpersvinculados90610
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and Fc gamma RIIb, which are modulated by anti-tumor necrosis factor therapy.pdf
Size:
920.47 KB
Format:
Adobe Portable Document Format
Description: